Name: 7th Annual MarketsandMarkets High Potent Medicines Conference [Time zone - (British Summer Time)]
Start: 2022-05-25
End: 2022-05-26
Location: Renaissance London Heathrow Hotel - Marriott

WHAT TO EXPECT

Process Development and scale up of HPAPI’s
Strategies for effective outsourcing partnership
Containment and Handling Strategies
Validation of cleaning procedures to avoid cross contamination
Regulatory Landscape
Hazard Assessment Classifications

Utilizing the best practices to ensure safe and efficient production of high potent medicines
Training sessions on complex high potent compounds handling and containment issues
Understanding the updated regulatory guidelines in the HPAPI process
Implementing response plans to react to an unplanned event
Knowing the outsourcing strategies to effectively build a reliable supply chain

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

Research & Development
Manufacturing/Operations/Production
Maintenance
Engineering
Risk Assessments
Laboratory Services/Analytical
New Technologies
Process Development/Technical transfer

CONFERENCE AGENDA

Registration	08:15 - 09:00
Welcome note from MarketsandMarkets	09:00 - 09:05
Opening Remarks from the Chairman Fred Ohsiek , Senior Validation Manager, Ecolab	09:05 - 09:10
Session 1: Process Development and Scale up
Keynote Presentation- Key considerations when choosing the right CDMO for the development and manufacturing of drug products containing HPAPI David O Connell , Director, Scientific Affairs, PCI Services, UK	09:10 - 09:50
Past, Present and Future of HPAPI Production- Olon Global Integrated Platform Paola Devoti, Corporate Project Engineering, Olon Spa, Italy	09:50 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Risk considerations for the contract manufacturing for of HPAPIs Anna Kuleza, Director CMC Pharmaceutical Development, Clovis Oncology, Switzerland	11:15 - 11:55
HPAPI milling and micronization contained system Stefano Butti , Sales Director, FPS	11:55 - 12:35
Manufacturing of Oncological Products Fabio Zenobi, EHS Director, BSP Pharmaceuticals, Italy	12:35 - 13:15
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:15 - 14:15
Does your CMO have what it takes to handle HPAPI’s? Richard Arnette, Manager, Industrial Hygiene and Toxicology, Pharmascience, Canada	14:15 - 14:55
Session 2: Containment & Handling
Ultra-potent pharmaceuticals: verifying containment Martin Axon, Senior Principal Occupational Hygienist , SafeBridge Europe	14:55 - 15:35
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:35 - 16:25
How to handle HPAPIs within Chemical Development (case studies) Thomas Adam, Head of Global Quality Assurance Chemical APIs, , Bayer, Germany	16:25 - 17:05
Closing Remarks from the Chairman	17:05 - 17:10
Drinks Reception & Networking	17:10 - 17:10
End of Day 1	17:10 - 17:10

Registration	08:15 - 09:00
Welcome note from MarketsandMarkets	09:00 - 09:05
Opening Remarks from the Chairman Fred Ohsiek , Senior Validation Manager, Ecolab	09:05 - 09:10
Maintaining the Cleaning Validation Program Fred Ohsiek , Senior Validation Manager, Ecolab	09:10 - 09:50
Session 3: Hazard Assessment and Cleaning Validation
Occupational Exposure Bands William Hawkins, Managing Toxicologist, SafeBridge Europe	09:50 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:30 - 11:15
Sustainable Cleaning Validation Kenneth Farrugia, Quality Assurance Manager , Natrix Sciences, Malta	11:15 - 12:15
Legacy Cleaning Validation Pitfalls and the Solution Fred Ohsiek , Senior Validation Manager, Ecolab	12:15 - 12:55
Closing remarks from the Chairman	12:55 - 13:00
End of Conference	13:00 - 13:00